Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos Computational Biology|December 17, 2013
Determinants of cell-to-cell variability in protein kinase signalingMatthias Jeschke, Stephan Baumgärtner, Stefan Legewie
Briefings in Bioinformatics|February 2, 2010
Flexible experimentation in the modeling and simulation framework JAMES II--implications for computational systems biologyRoland Ewald, Jan Himmelspach, Matthias Jeschke, et al.
Cancers|February 26, 2025
Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE)Hannah L Steinberg-Vorhoff, Andriana Tropotel, Jens M Theysohn, et al.
Cancers|July 13, 2024
Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter TrialVera Himmelsbach, Matthias Jeschke, Christian M Lange, et al.
Liver Cancer|January 23, 2026
No More Detours: Hepatopulmonary Shunt Reduction in a Patient with Hepatocellular Carcinoma after Treatment with BevacizumabMatthias Jeschke, Julia M Schütte, Stephan Himmen, et al.
European Journal of Radiology Open|February 2, 2026
Muscle and fat matter: Automated CT-based body composition analysis predicts survival in Hepatocellular carcinoma patients undergoing radioembolizationHannah L Steinberg-Vorhoff, Anneke Ketelsen, Tabea Schuch, et al.
Cancers|September 9, 2023
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/BevacizumabMatthias Jeschke, Johannes M Ludwig, Catherine Leyh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90Y Glass MicrospheresMasao Watanabe, Hong Grafe, Jens Theysohn, et al.
Cancers|April 23, 2022
Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World AnalysisCatherine Leyh, Ursula Ehmer, Daniel Roessler, et al.
Therapeutic Advances in Medical Oncology|March 7, 2022
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experienceTiago de Castro, Leonie S Jochheim, Melanie Bathon, et al.
Pageof 1